Arbutus Biopharma Corp Investments and Cash
Arbutus Biopharma Corp (ABUS) had Investments and Cash of $92.60 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2026-08-12
- 2026-06-30: Investments and Cash $92.60M.
- 2026-03-31: Investments and Cash $95.20M.
- 2025-09-30: Investments and Cash $93.70M.
- 2025-06-30: Investments and Cash $98.10M.
| Period end | Investments and Cash |
|---|---|
| 2026-06-30 | $92.60M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $95.20M 10-Q · filed 2026-05-13 |
| 2025-09-30 | $93.70M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $98.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $112.70M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $130.80M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $148.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $137.90M 10-Q · filed 2024-05-02 |
| 2023-09-30 | $144.70M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $163.50M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $178.50M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $190.20M 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |